cholecalciferol has been researched along with Dermatitis* in 5 studies
2 review(s) available for cholecalciferol and Dermatitis
Article | Year |
---|---|
The vitamin D pathway: a new target for control of the skin's immune response?
The surface of our skin is constantly challenged by a wide variety of microbial pathogens, still cutaneous infections are relatively rare. Within cutaneous innate immunity the production of antimicrobial peptides (AMPs) is a primary system for protection against infection. Many AMPs can be found on the skin, and these include molecules that were discovered for their antimicrobial properties, and other peptides and proteins first known for activity as chemokines, enzymes, enzyme inhibitors and neuropeptides. Cathelicidins were among the first families of AMPs discovered on the skin. They are now known to have two distinct functions; they have direct antimicrobial activity and will initiate a host cellular response resulting in cytokine release, inflammation and angiogenesis. Dysfunction of cathelicidin is relevant in the pathogenesis of several cutaneous diseases including atopic dermatitis where cathelicidin induction is suppressed, rosacea, where cathelicidin peptides are abnormally processed to forms that induce cutaneous inflammation and a vascular response, and psoriasis, where a cathelicidin peptide can convert self-DNA to a potent stimulus of an autoinflammatory cascade. Recent work has unexpectedly identified vitamin D3 as a major factor involved in the regulation of cathelicidin expression. Therapies targeting the vitamin D3 pathway and thereby cathelicidin may provide new treatment modalities in the management of infectious and inflammatory skin diseases. Topics: Animals; Cathelicidins; Cholecalciferol; Dermatitis; Gene Expression Regulation; Humans; Immunity, Innate; Models, Biological; Skin; T-Lymphocytes | 2008 |
[New relevance of vitamin D3 metabolism in the skin].
Epidermal keratinocytes are the site of both UVB-induced photochemical conversion of 7-dehydrocholesterol to vitamin D(3) (25 OHD(3)) and the enzymatically controlled hydroxylation via 25-hydroxyvitamin D(3) to the biologically active final product 1alpha,25-dihydroxy vitamin D(3) (1alpha,25(OH)(2)D(3), calcitriol). The epidermal synthesis of calcitriol is of fundamental relevance because calcitriol regulates important cellular functions in keratinocytes and dermal immunocompetent cells. Calcitriol and other vitamin D-analogues are effective in the treatment of psoriasis because of their anti-proliferative and pro-differentiation effects. One mechanism for UVB-light therapy in psoriasis could be the induction of calcitriol synthesis. A better understanding of the metabolism of vitamin D(3) in the skin opens new perspectives for potential therapeutic applications of vitamin D analogues in inflammatory skin diseases. Further studies investigating the role of vitamin D(3) metabolism in the prevention of malignant skin disorders are needed. Topics: Cholecalciferol; Dermatitis; Humans; Psoriasis; Skin Diseases; Ultraviolet Rays; Ultraviolet Therapy | 2004 |
1 trial(s) available for cholecalciferol and Dermatitis
Article | Year |
---|---|
Effect of Cholecalciferol Supplementation on Treatment Response and IL-10 Level in Vitamin D Deficient
Allergic contact dermatitis following exposure to Topics: Allergens; Cholecalciferol; Dermatitis; Dietary Supplements; Double-Blind Method; Female; Humans; Interleukin-10; Male; Middle Aged; Plant Weeds; Quality of Life; Severity of Illness Index; Vitamin D; Vitamin D Deficiency; Vitamins | 2020 |
2 other study(ies) available for cholecalciferol and Dermatitis
Article | Year |
---|---|
Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation.
Human skin immune homeostasis, and its regulation by specialized subsets of tissue-residing immune sentinels, is poorly understood. In this study, we identify an immunoregulatory tissue-resident dendritic cell (DC) in the dermis of human skin that is characterized by surface expression of CD141, CD14, and constitutive IL-10 secretion (CD141(+) DDCs). CD141(+) DDCs possess lymph node migratory capacity, induce T cell hyporesponsiveness, cross-present self-antigens to autoreactive T cells, and induce potent regulatory T cells that inhibit skin inflammation. Vitamin D(3) (VitD3) promotes certain phenotypic and functional properties of tissue-resident CD141(+) DDCs from human blood DCs. These CD141(+) DDC-like cells can be generated in vitro and, once transferred in vivo, have the capacity to inhibit xeno-graft versus host disease and tumor alloimmunity. These findings suggest that CD141(+) DDCs play an essential role in the maintenance of skin homeostasis and in the regulation of both systemic and tumor alloimmunity. Finally, VitD3-induced CD141(+) DDC-like cells have potential clinical use for their capacity to induce immune tolerance. Topics: Analysis of Variance; Animals; Antigens, Surface; Cell- and Tissue-Based Therapy; Cholecalciferol; Dermatitis; Female; Graft vs Host Disease; Homeostasis; Humans; Indoles; Interleukin Receptor Common gamma Subunit; Interleukin-10; Langerhans Cells; Lipopolysaccharide Receptors; Male; Mice; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; T-Lymphocytes, Regulatory; Thrombomodulin | 2012 |
Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo.
Macrophage-derived chemokine (MDC)/CCL22 is a CC chemokine active on dendritic cells (DC), NK cells and Th2 lymphocytes. The present study was aimed at comprehensively investigating MDC production in vitro and in vivo. DC were the most potent producers of MDC among leukocytes tested. Endothelial cells did not produce MDC under a variety of conditions. Signals that induce maturation (lipopolysaccharide, IL-1, TNF, CD40 ligand, recognition of bacteria and yeast) dramatically augmented MDC production, and dexamethasone and vitamin D3 blocked it. Prostaglandin E(2), which blocked the acquisition of IL-12 production and the capacity to promote Th1 generation, did not affect MDC production. Using mass spectrometry-based techniques, DC supernatants were found to contain N-terminally truncated forms of MDC [MDC(3-69), MDC(5-69) and MD(C7-69)] as well as the full-length molecule. In vivo, CD1a(+), CD83(+), MDC(+) DC were found in reactive lymph nodes, and in Langerhans' cell histiocytosis. Skin lesions of atopic dermatitis patients showed that CD1a(+) or CD1b(+) DC, and DC with a CD83(+) phenotype were responsible for MDC production in this Th2-oriented disorder. Thus, DC are the predominant source of MDC in vitro and in vivo under a variety of experimental and clinical conditions. Processing of MDC to MDC(3-69) and shorter forms which do not recognize CCR4 is likely to represent a feedback mechanism of negative regulation. Topics: Cells, Cultured; Chemokine CCL22; Chemokines, CC; Cholecalciferol; Chromatography, High Pressure Liquid; Dendritic Cells; Dermatitis; Dexamethasone; Dinoprostone; Endocytosis; Histiocytosis, Langerhans-Cell; Humans; Leukocytes; Lipopolysaccharides; Lymphatic Diseases; Mass Spectrometry; Monocytes; Protein Isoforms; RNA, Messenger; Transcriptional Activation | 2001 |